Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pulse Biosciences CS (NQ: PLSE )

14.56 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pulse Biosciences CS

< Previous 1 2 3 4 5 6 7 8 9 Next >
Pulse Biosciences Stock Is Trading Higher After Company's Chairman Agrees To Buy Shares Worth $50M
Pulse Biosciences Inc's (NASDAQ: PLSE) Board Chairman, Robert W. Duggan, will purchase 3.04 million common shares at $16.40 per share in a private placement. All... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Alterity Therapeutics (NASDAQ:ATHE 
Via Benzinga
30 Stocks Moving In Thursday's Mid-Day Session
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 104.6% to $62.00. Pop Culture Group shares jumped 405% on Wednesday after the company priced its IPO at $6 per... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Pulse Biosciences Announces $50 Million Private Placement
From Pulse Biosciences, Inc.
Via Business Wire
Earnings Scheduled For May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
Via Benzinga
Want to Buy Pulse Biosciences (NASDAQ: PLSE) Stock? See This First.
Pulse Biosciences (NASDAQ: PLSE) is a bioelectric medicine firm, working on innovative health products across a wide range of conditions. With 99 issued patients, Pulse is... 
Via Benzinga
Pulse Biosciences Announces First CellFX® Procedure Performed in Canada
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Announces Health Canada Approval for CellFX® System
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences to Participate in the Jefferies Healthcare Conference
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences® Presents Clinical Study Results of Nano-Pulse Stimulation™ Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual Conference
From Pulse Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Curis (NASDAQ:CRIS) shares moved upwards by 57.23% to $15.46 during Wednesday's regular session. Trading volume for Curis's stock is 28.8 million as of 12:... 
Via Benzinga
Pulse Biosciences Reports First Quarter 2021 Financial Results
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Schedules First Quarter 2021 Financial Results Conference Call for May 10, 2021
From Pulse Biosciences, Inc.
Via Business Wire
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
Pulse Biosciences to Present Consumer Research on Patient Perceptions of Benign Lesion Clearance at American Academy of Dermatology VMX Meeting 2021
From Pulse Biosciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.